Related Experiment Videos
A computational model for anthracycline binding to DNA: tuning groove-binding intercalators for specific sequences
Derek J Cashman1, Glen E Kellogg
1Department of Medicinal Chemistry and Institute for Structural Biology & Drug Discovery, School of Pharmacy, Virginia Commonwealth University, P.O. Box 980540, Richmond, Virginia 23219-0540, USA.
Journal of Medicinal Chemistry
|March 5, 2004
Summary
Computational analysis identified specific doxorubicin analogues with potential for targeted gene modulation and reduced toxicity. These findings guide the development of novel anticancer drugs with improved DNA binding sequence selectivity.
Area of Science:
- Medicinal Chemistry
- Computational Biology
- Pharmacology
Background:
- Anthracyclines, like doxorubicin, are established anticancer drugs with a long history of use.
- Ongoing research aims to develop analogues with enhanced DNA binding sequence specificity for improved efficacy and reduced toxicity.
- Understanding these binding interactions is crucial for designing next-generation chemotherapeutics.
Purpose of the Study:
- To computationally analyze the DNA binding sequence specificity of 65 doxorubicin analogues.
- To identify structural features that confer enhanced sequence selectivity and potency.
- To present efficient computational methods for evaluating drug-target interactions.
Main Methods:
- Construction of molecular models for 65 doxorubicin analogues and eight DNA octamer sequences.
- Utilized the HINT (Hydropathic INTeractions) program to assess binding free energy and sequence selectivity.
- Calculated DeltaDeltaG(sel) values to quantify sequence-specific binding affinities.
Main Results:
- Two analogues exhibited high sequence selectivity (DeltaDeltaG(sel) > -0.75 kcal mol(-1)).
- Ten analogues showed significant selectivity (-0.50 to -0.74 kcal mol(-1)), and 18 showed moderate selectivity (-0.25 to -0.49 kcal mol(-1)).
- Identified key structural modifications, such as halogen or nonaromatic ring substitutions and methoxy group removal, enhancing selectivity and potency.
Conclusions:
- Efficient computational methods can accurately predict doxorubicin analogue DNA binding and sequence selectivity.
- Structural modifications, including those in the daunosamine sugar and aglycone regions, are critical for optimizing drug properties.
- This study provides a foundation for designing novel doxorubicin analogues with tailored anticancer activity and reduced side effects.